XML 94 R73.htm IDEA: XBRL DOCUMENT v3.25.4
Provision for Income Taxes - Schedule of Reconciliation of Income Taxes at the Statutory Federal Income Tax Rate to Net Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Jan. 02, 2026
Jan. 03, 2025
Dec. 29, 2023
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]      
U.S. federal statutory tax rate $ 197,653 $ 143,144 $ 54,080
State and local income taxes, net of federal income tax effect 11,015 12,240 (1,487)
Effects of cross-border tax laws:      
Foreign-derived intangible income (28,011)    
Tax credits:      
Research and development tax credits (23,941) (10,997) (23,714)
Nontaxable or nondeductible items:      
Non-deductible executive compensation 14,220 7,094 7,019
Branded prescription drug fee 5,100 4,633 4,968
Stock-based compensation (23,029) 665 1,066
Changes in unrecognized tax benefits 3,933    
Change in valuation allowance   (3,617) 5,770
Other 1,696 7,211 2,054
Provision for income taxes and effective income tax rate $ 158,636 $ 160,373 $ 49,756
Increase/(decrease) in tax rate resulting from:      
U.S. federal statutory tax rate 21.00%    
State and local income taxes, net of federal income tax effect 1.20%    
Effects of cross-border tax laws:      
Foreign-derived intangible income (3.00%)    
Tax credits:      
Research and development tax credits (2.50%)    
Nontaxable or nondeductible items:      
Non-deductible executive compensation 1.50%    
Branded prescription drug fee 0.50%    
Stock-based compensation (2.40%)    
Changes in unrecognized tax benefits 0.40%    
Other 0.20%    
Provision for income taxes and effective income tax rate 16.90%